You are here: Welcome » pharmaceutical_companies » Providence Therapeutics

Menu

Rounding The Earth

Operation Uplift

Project List

This is an old revision of the document!

Providence Therapeutics

Providence Therapeutics is a Canadian biotechnology company based in Calgary, Alberta, with additional operations in Toronto, Ontario. The company specializes in messenger RNA (mRNA) vaccines.1)

History

COVID-19

In April 2020, Providence created a fully “made-in-Canada” mRNA COVID-19 vaccine called PTX-COVID19-B.2)

One year later in April 2021, Providence founder Brad Sorenson announced he was fed up with the lack of support from the Canadian government and would be relocating operations overseas.3)

Affiliations

Personnel

Providence Therapeutics personnel4)
Name Role Affiliations
Jared Davis President Arcturus Therapeutics, Alexion
Brad Sorenson Founder & CEO Arcturus Therapeutics
Aleksandra Pastrak Chief Medical Officer OPKO Health, Transition Therapeutics
Natalia Martin Orozco Chief Science Officer Merck, Iovance, Bellicum Pharmaceuticals
Ken Hughes Chair of the Board of Directors Institute of Corporate Directors, Alberta Health Services, Alpine Insurance & Financial
Scott Leary Co-founder & board member SENTA Clinic, Scripps Health
Eric Marcusson Co-founder & board member Isis Pharmaceuticals, Regulus Therapeutics
Donna T. Ward Board member Ionis Pharmaceuticals, Alnylam Pharmaceuticals, DT Ward, PC
Pam Ohashi Scientific Advisory Board chair University of Toronto, Canada Research Chair, Princess Margaret Cancer Centre, American Association for Cancer Research
Brian Barber Scientific Advisory Board member University of Toronto, University Health Network, Sanofi Pasteur, Mojave Therapeutics
Art Krieg Scientific Advisory Board member Translate Bio, Checkmate Pharmaceuticals, Coley Pharmaceuticals, Sarepta Pharmaceuticals, Pfizer, Atlas Ventures, RNA Therapeutics Institute at the University of Massachusetts, Oligonucleotide Therapy Society
Amit Oza Lead Clinician University Health Network, Mount Sinai Health System, Princess Margaret Cancer Centre, BRAS Drug Development Program

Funding

In November 2021, the Bill & Melinda Gates Foundation gave $2,118,334 to Providence Therapeutics to develop more cost-effective mRNA vaccines.5)

Rumours

On February 13, 2022, an article was published on Substack that claimed Canadian Prime Minister Justin Trudeau was a former or current owner of Providence, and as such, had profited greatly from the worldwide use of COVID-19 vaccines.6) The article alleged that Providence-related patents owned by the University of British Columbia (UBC) had been transferred into Trudeau's name (with the help of Klaus Schwab and Bill Gates, subsequently licensed to Moderna and Pfizer, and then sold to Everest Medicines in China.

1)
About Providence Therapeutics. (2022). Providence Therapeutics. https://web.archive.org/web/20220711155818/https://providencetherapeutics.com/about.html
2)
Providence Therapeutics PTX–COVID19–B. (2022). Providence Therapeutics. https://providencetherapeutics.com/pipeline/ptx-covid19-b.html
3)
Tasker, J. P. (2021, April 30). COVID-19 vaccine maker Providence says it’s leaving Canada after calls for more federal support go unanswered. CBC News. https://web.archive.org/web/20220711165025/https://www.cbc.ca/news/politics/providence-therapeutics-pulling-out-canada-1.6009068
4)
Meet the Team of Providence Therapeutics. (2022). Providence Therapeutics. https://web.archive.org/web/20220711155842/https://providencetherapeutics.com/about/meet-the-team#scientific-advisory
5)
Providence Therapeutics. (2021, November). Bill & Melinda Gates Foundation. https://archive.ph/f8CM8
6)
bilbobitch. (2022, February 13). Trudeau Recently Sold the mRNA Patents to China for $500M USD - Trudeau may have won the lottery. Bilbobitch’s Newsletter; Substack. https://bilbobitch.substack.com/p/trudeau-recently-sold-the-mrna-patents
Back to top